Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 4
2014 9
2015 5
2016 9
2017 5
2018 4
2019 3
2020 4
2021 7
2022 3
2023 6
2024 2
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. Blockmans D, et al. N Engl J Med. 2025 May 29;392(20):2013-2024. doi: 10.1056/NEJMoa2413449. Epub 2025 Apr 2. N Engl J Med. 2025. PMID: 40174237 Clinical Trial.
Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.
Rosales-Alexander JL, Balsalobre Aznar J, Magro-Checa C. Rosales-Alexander JL, et al. Among authors: magro checa c. Open Access Rheumatol. 2014 May 8;6:39-47. doi: 10.2147/OARRR.S39039. eCollection 2014. Open Access Rheumatol. 2014. PMID: 27790033 Free PMC article. Review.
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes IB, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. Alunno A, et al. Among authors: magro checa c. Ann Rheum Dis. 2022 Jan;81(1):34-40. doi: 10.1136/annrheumdis-2021-221366. Epub 2021 Oct 7. Ann Rheum Dis. 2022. PMID: 34620584 Free article.
Recurrent parotid pseudogout.
Rosales Alexander JL, Magro Checa C, Salvatierra J, Caba Molina M, Raya Álvarez E. Rosales Alexander JL, et al. Among authors: magro checa c. Rheumatology (Oxford). 2012 Dec;51(12):2169. doi: 10.1093/rheumatology/kes265. Epub 2012 Oct 1. Rheumatology (Oxford). 2012. PMID: 23033502 No abstract available.
Demyelinating disease in SLE: is it multiple sclerosis or lupus?
Magro Checa C, Cohen D, Bollen EL, van Buchem MA, Huizinga TW, Steup-Beekman GM. Magro Checa C, et al. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):405-24. doi: 10.1016/j.berh.2013.07.010. Best Pract Res Clin Rheumatol. 2013. PMID: 24238696 Review.
C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus.
van Schaarenburg RA, Magro-Checa C, Bakker JA, Teng YK, Bajema IM, Huizinga TW, Steup-Beekman GM, Trouw LA. van Schaarenburg RA, et al. Among authors: magro checa c. Front Immunol. 2016 Dec 27;7:647. doi: 10.3389/fimmu.2016.00647. eCollection 2016. Front Immunol. 2016. PMID: 28082982 Free PMC article.
61 results